Sartorius has extended a strategic collaboration agreement with RoosterBio Inc. to address purification challenges and establish scalable downstream manufacturing processes for exosome-based therapies. The companies will provide solutions and expertise for a human mesenchymal stem/stromal cell (hMSC) – based exosome production platform that aims to deliver industry-leading yield, purity, and potency. This collaboration will also […]

The post Sartorius, RoosterBio Partner to Advance the Manufacture of Exosomes first appeared on World Pharma Today.